Prof. Movahedi studies how a class of immune cells called macrophages affect the development and progression of brain disorders. This includes neurodegenerative disorders such as Alzheimer's disease or multiple sclerosis, and aggressive primary brain tumors called glioblastomas. The Movahedi lab aims to develop new therapies for these diseases by modulating the functions of brain macrophages.
"I am extremely honored to receive the Collen-Francqui start-up grant. Not only is it a great recognition for our work, but it also gives us increased freedom to pursue an ambitious research line. The generous funding will allow us to further investigate the role of brain macrophages in neurological diseases, which in time will hopefully lead to new treatment options for patients."
+32 (0)2 477 45 69